MetaStat Inc
MTST
Rank in Stocks
#34704
MetaStat, Inc., a precision medicine company, focuses on discovering and... MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The company is developing novel drug candidates and companion diagnostic tests that target the MENA pathway. Its product candidates include MENA diagnostic assay, a tissue-based quantitative immunofluorescence test that measures expression of the pro-metastatic MENA protein splice-variant; companion diagnostic to predict RTK inhibitor drug responses and anti-microtubule drug responses; liquid blood-based biopsy to enhance cancer diagnosis and optimize patient care; MetaSite Breast assay, an immunohistochemistry test that measures micro-anatomical intravasat at blood vessels within the tumor microenvironment ion sites; and prognostic diagnostic to predict risk of cancer metastasis. The companyโs therapeutic targets a critical metastatic pathway in solid tumors responsible for driving tumor resistance and the spread of aggressive cancer. MetaStat, Inc. is based in Boston, Massachusetts.
Share Price
$0.0007
Last synced: 2026-11-10
Market Cap
$3.92K
Change (1 day)
0.00%
Change (1 year)
133.33%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade MetaStat Inc (MTST)
Category
Industrials
EPS for MetaStat Inc (MTST)
EPS as of February 2018 TTM: $-0.58
According to MetaStat Inc's latest financial reports, its current EPS (TTM) is $-0.58. At the end of 2018 the company had an EPS of $-0.59, an increase over its 2017 EPS of $-0.99.
EPS history for MetaStat Inc from 2008 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.58 | -1.69% |
| 2018 | $-0.59 | -40.40% |
| 2017 | $-0.99 | -61.33% |
| 2016 | $-2.56 | -46.78% |
| 2015 | $-4.81 | 26.58% |
| 2014 | $-3.80 | 109.94% |
| 2013 | $-1.81 | -19.56% |
| 2012 | $-2.25 | 1,400.00% |
| 2011 | $-0.15 | -94.70% |
| 2010 | $-2.83 | -75.41% |
| 2009 | $-11.51 | 148.60% |
| 2008 | $-4.63 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.76 | -575.86% |
CH
|
|
| $2.88 | -596.86% |
CN
|
|
| $10.03 | -1,829.31% |
IE
|
|
| $5.47 | -1,043.10% |
US
|
|
| $0.07 | -112.38% |
TH
|
Questions about MetaStat Inc's earnings per share (EPS)
What is MetaStat Inc's earnings per share (EPS)?
MetaStat Inc's earnings per share (EPS) over the last twelve months is $-0.58, as of Feb 2018.
What was MetaStat Inc's earnings per share (EPS) in 2018?
In 2018, MetaStat Inc's earnings per share (EPS) was $-0.59, compared with $-0.99 in 2017.
How has MetaStat Inc's earnings per share (EPS) changed since 2013?
From 2013 to 2018, MetaStat Inc's earnings per share (EPS) was highest in 2018 ($-0.59) and lowest in 2015 ($-4.81).
How does MetaStat Inc's earnings per share (EPS) compare with similar companies?
MetaStat Inc's earnings per share (EPS) ($-0.58) is lower than that of all 5 similar companies listed above. The highest among them is Eaton Corporation plc, with $10.03.